Clinical Trials Directory

Trials / Completed

CompletedNCT07077928

Effects of Upgrading From Right Ventricular Pacing to Cardiac Resynchronization Therapy and Comparison With Dual-Chamber Defibrillator

Status
Completed
Phase
Study type
Observational
Enrollment
307 (actual)
Sponsor
Bursa Postgraduate Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients who consecutively underwent de novo CRT implantation, CRT upgrade, and DDDR ICD implantation at the Cardiology Clinic of Bursa Postgraduate Hospital between January 2019 and December 2023 according to the European Society of Cardiology (ESC) guideline criteria were included in the study.

Detailed description

100 patients receiving de-novo CRT, 38 patients upgrading from RV pacing to CRT, and 169 patients receiving a DDDR-ICD implantation were included the study. Inclusion criteria were left ventricular ejection fraction lower than 35% and either QRS longer than 130ms for CRT groups or QRS≤120ms for the DDDR-ICD group. Primary endpoints were all-cause mortality and hospitalization for heart failure during a follow-up period extending up to 5 years.

Conditions

Interventions

TypeNameDescription
DEVICEPacemaker upgradeCRT upgrade

Timeline

Start date
2019-01-01
Primary completion
2023-12-01
Completion
2023-12-31
First posted
2025-07-22
Last updated
2025-07-22

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07077928. Inclusion in this directory is not an endorsement.